What is the role of surgery in potentially resectable N2 non-small cell lung cancer?
- 9 October 2018
- Vol. 73 (12), 1105-1109
- https://doi.org/10.1136/thoraxjnl-2018-212287
Abstract
### Key messages Stage III/N2 non-small cell lung cancer (NSCLC) describes the metastatic spread of a primary tumour to the ipsilateral mediastinal lymph nodes. It is a heterogeneous disease stage ranging from unsuspected N2 disease only detected by intraoperative lymph node sampling during surgical resection of the primary tumour to conglomerate, bulky and invasive N2 disease that cannot be resected. For unresectable N2 NSCLC concurrent chemoradiotherapy is widely accepted as the standard of care in the context of appropriate physiological reserve.1–3 Between these two ends of the spectrum sit those patients with discrete and potentially resectable N2 disease. The optimal treatment strategy in this patient group is keenly debated and a number of guidelines from the UK, Europe and America have made recommendations.1–3 The aim of this article is to review these guidelines and provide an interpretation of their recommendations as a guide to clinicians involved in the care of patients with potentially resectable N2 NSCLC. A summary of the key randomised controlled trials (RCTs) in resectable N2 NSCLC that form the basis of these …Keywords
This publication has 13 references indexed in Scilit:
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2017
- Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)Journal of Clinical Oncology, 2015
- Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialThe Lancet, 2015
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerAnnals Of Oncology, 2015
- Treatment of Stage III Non-small Cell Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Guidelines on the radical management of patients with lung cancerThorax, 2010
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialThe Lancet, 2009
- The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2007
- Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2007